Drugs.com - Pharma Industry News

Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea

MONDAY, June 9, 2025 -- Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients preferring tirzepatide, according...

Jun 9, 2025 - 19:00
 0
Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
MONDAY, June 9, 2025 -- Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients preferring tirzepatide, according...
Read More

Tags:

Previous Article

Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk

Next Article

Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk

Related Posts

Pathological Fatigue Common Up to 12 Months After TIA

Pathological Fatigue Common Up to 12 Months After TIA

May 15, 2025  0

Multitarget Stool DNA Tests More Costly Than FIT for Colorectal Cancer Detection

Multitarget Stool DNA Tests More Costly Than FIT for Co...

May 15, 2025  0

Pod-Style E-Cigarettes May Have Higher Abuse Liability Than Nicotine Gum

Pod-Style E-Cigarettes May Have Higher Abuse Liability ...

May 29, 2025  0